(Adnkronos) - "Le malattie respiratorie rappresentano un rischio e un costo per il Ssn. La vera sfida è riuscire a coprire la popolazione anziana e fragile per tutte quelle malattie infettive respiratorie che possono avere una copertura vaccinale. Da quest’anno abbiamo un’arma in più, i vaccini contro il virus respiratorio sinciziale". Così la presidente della Società italiana d’Igiene, medicina preventiva e sanità pubblica (SItI), Roberta Siliquini durante la presentazione – a Roma – della campagna di sesibilizzazione promossa da Pfizer ‘Abituati a proteggerti dalle infezioni respiratorie’.
Category
🗞
NewsTranscript
00:00The respiratory infection, before representing a cost, represents a risk for certain types
00:10of patients, so they must be protected, and then certainly also a cost for society, for
00:16increasing access to the national emergency medical service, rather than indirect costs
00:22related to the care of the sick person.
00:26The challenge is to be able to cover the elderly and the frail population for all the respiratory
00:33infectious pathologies that can have a vaccine prevention.
00:38Fortunately, there are many, because in addition to the influenza, COVID and pneumococcal pneumonia,
00:47this year we have another weapon against the respiratory infection, which are vaccines
00:55against the respiratory virus, which has more or less the same characteristics, it
01:01identifies the same frail patients, but which is probably more underestimated, being a
01:08pathology, a very widespread virus, also in the whole family, let's say, it affects
01:15from the newborn to the elderly adult patient.
01:18We know the costs in terms of human lives, the influenza causes about 8,000 deaths a year,
01:27so the COVID and the RSV, perhaps a few lives less, but certainly a fairly high number of hospitalizations.